Contouring for Genitourinary Cancer

This activity will evaluate contouring principles for patients with genitourinary malignancies and includes discussion about prostate cancers (definitive and post-operative) and bladder cancer.

The content was originally presented and recorded at the 2026 ASTRO Annual Refresher Course

This activity includes a didactic background lecture and case/contour review. It does not include the hands-on practice cases.

This activity is available from July 9, 2026, through July 8, 2028.

Target Audience

This course is designed to meet the interest of radiation oncologists and radiation oncology residents.

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Evaluate CTV delineations for prostate (definitive and post-operative), kidney, and bladder cancers.
  • Discuss OAR and GTV delineation for intact prostate cancer.
  • Discuss motion management principles for prostate (definitive and post-operative), kidney, and bladder cancers.

Course summary

Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
07/09/2026
Course expires: 
07/08/2028
Cost:
$149.00
Rating: 
0

Speaker

  • Amar Kishan, MD, is employed by UCLA. Dr. Kishan receives Consultant role honoraria from Varian Medical Systems and Boston Scientific. Dr. Kishan receives grant/research funding (institution) from Janssen, Inc., Point BioPharma and ViewRay Systems and grant/research funding (individual) from Lantheus and Novartis. Dr. Kishan has ownership equity in MiraDx.

Planner/Moderator Disclosures

  • Megan Daly, MD, is employed by University of California Davis.  Dr. Daly receives grant/research funding (institution) from Genentech and honoraria from AstraZeneca. Dr. Daly received grant/research funding (institution) from Merck [relationship ended December 2025] and honoraria from Dava [relationship ended October 2024]; Novocure [relationship ended November 2024]; and Bristol Myers Squibb [relationship ended November 2024].
  • Sue Yom, MD, PhD, FASTRO, is employed by University of California San Francisco. Dr. Yom receives grant/research funding (institution) from Bristol Myers Squibb, EMD Serono and Johnson & Johnson.  

The person(s) above served as the developer(s) of this activity. 

All relevant financial relationships have been mitigated.

 

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$149.00
Please login or register to take this course.

Activity Fees

This activity is included in the ASTRO Academy Subscription. To purchase the subscription beginning December 1, 2026, please go to the ASTRO Product Catalog.

ASTRO members and Academy subscribers must log in to the ASTRO Academy to view and receive the corresponding rate:

  • Academy Subscriber: $0
  • Member: $99
  • Member-in-Training / Student Member / Postdoctoral Fellow Member: $49
  • Nonmember: $149

Discounts
Please email ASTRO eLearning to inquire about the discounts below.

  • If you are an ASTRO member residing in a low- or lower-middle-income economy country, as identified by the World Bank, you can receive a 50% discount off the activity fee.
  • If you are an ASTRO member residing in an upper-middle-income economy country, as identified by the World Bank, you can receive a 25% discount off the activity fee.

Policies

No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until the Activity expiration date, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.

Copyright of all aspects of ASTRO Academy Content, including recordings and/or reproductions of sessions, programs, presentations, discussions and other scheduled events (“ASTRO Academy Content”) is owned by ASTRO. Only ASTRO reserves the rights to all ASTRO Academy Content, including to digitize, modify, alter, edit, adapt, create derivative works, display, publicly perform, exhibit, transmit, broadcast, reproduce, exploit, sell, rent license, otherwise use, and permit others to use, such ASTRO Academy Content. Photographing, filming, taping, recording or any form of capture or reproduction in any medium of any aspect of ASTRO Academy Content, including, but not limited to the programs, presentations, material, sessions, and discussions, or on the Academy platform are strictly forbidden without written authorization from ASTRO.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.